The antibody-drug conjugate, commonly known as Enhertu, is among the drugs that will be added to China's state-run medical insurance from Jan. 1, the list showed. Enhertu, co-developed with Japan ...
SHANGHAI, Nov 28 (Reuters) - AstraZeneca's (AZN.L), opens new tab blockbuster breast cancer drug Enhertu will be added to China's state-run health insurance scheme from Jan. 1, according to an ...
Enhertu is already approved or has accelerated approval for the treatment of several cancers involving HER mutations, including breast cancer, non-small cell lung cancer, gastroesophageal junction ...